Skip to Content

M LC 450 (Lithium Carbonate Extended Release 450 mg)

Pill with imprint M LC 450 is White, Round and has been identified as Lithium Carbonate Extended Release 450 mg. It is supplied by Mylan Pharmaceuticals Inc..

Lithium is used in the treatment of bipolar disorder; schizoaffective disorder; mania and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M LC 450

Lithium carbonate extended release 450 mg M LC 450

Lithium Carbonate Extended Release

Imprint
M LC 450
Strength
450 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Antimanic agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-1450 Mylan Pharmaceuticals Inc.
51079-0142 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.